These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36769184)

  • 1. Expression of RBMS3 in Breast Cancer Progression.
    Górnicki T; Lambrinow J; Mrozowska M; Romanowicz H; Smolarz B; Piotrowska A; Gomułkiewicz A; Podhorska-Okołów M; Dzięgiel P; Grzegrzółka J
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA.
    Block CJ; Mitchell AV; Wu L; Glassbrook J; Craig D; Chen W; Dyson G; DeGracia D; Polin L; Ratnam M; Gibson H; Wu G
    Oncogene; 2021 Nov; 40(46):6430-6442. PubMed ID: 34608266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
    Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
    Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Suppressor Effect of RBMS3 in Breast Cancer.
    Wang C; Wu Y; Liu Y; Pan F; Zeng H; Li X; Yu L
    Technol Cancer Res Treat; 2021; 20():15330338211004921. PubMed ID: 33910421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBMS3 Inhibits the Proliferation and Metastasis of Breast Cancer Cells.
    Yang Y; Quan L; Ling Y
    Oncol Res; 2018 Jan; 26(1):9-15. PubMed ID: 28409548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression.
    Zhu L; Xi PW; Li XX; Sun X; Zhou WB; Xia TS; Shi L; Hu Y; Ding Q; Wei JF
    J Exp Clin Cancer Res; 2019 Feb; 38(1):105. PubMed ID: 30819235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of RBMS3 predicts a favorable prognosis in human gallbladder carcinoma.
    Wu Y; Meng D; You Y; Sun R; Yan Q; Bao J; Sun Y; Yun D; Li Y; Sun D
    Oncol Rep; 2020 Jul; 44(1):55-68. PubMed ID: 32627033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of periostin in breast cancer cells.
    Ratajczak-Wielgomas K; Grzegrzolka J; Piotrowska A; Matkowski R; Wojnar A; Rys J; Ugorski M; Dziegiel P
    Int J Oncol; 2017 Oct; 51(4):1300-1310. PubMed ID: 28902360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Expression of PIWIL1 and PIWIL2 and Their Clinical Significance in Ductal Breast Carcinoma.
    Litwin M; Szczepańska-Buda A; Michałowska D; Grzegrzółka J; Piotrowska A; Gomułkiewicz A; Wojnar A; Dzięgiel P; Witkiewicz W
    Anticancer Res; 2018 Apr; 38(4):2021-2030. PubMed ID: 29599319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of metallothionein 3 in ductal breast cancer.
    Gomulkiewicz A; Jablonska K; Pula B; Grzegrzolka J; Borska S; Podhorska-Okolow M; Wojnar A; Rys J; Ambicka A; Ugorski M; Zabel M; Dziegiel P
    Int J Oncol; 2016 Dec; 49(6):2487-2497. PubMed ID: 27840910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma.
    Pula B; Olbromski M; Wojnar A; Gomulkiewicz A; Witkiewicz W; Ugorski M; Dziegiel P; Podhorska-Okolow M
    Cell Oncol (Dordr); 2013 Dec; 36(6):469-83. PubMed ID: 24065215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of RBMS3 suppresses PD-L1 and enhances antitumor immune activities and therapeutic effects of auranofin against triple-negative breast cancer.
    Zhou Y; Liang Z; Xia Y; Li S; Liang J; Hu Z; Tang C; Zhao Q; Gong Q; Ouyang Y
    Chem Biol Interact; 2023 Jan; 369():110260. PubMed ID: 36414028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of NUCB2/NESF-1 in Breast Cancer Cells.
    Kmiecik A; Ratajczak-Wielgomas K; Grzegrzółka J; Romanowicz H; Smolarz B; Dziegiel P
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma.
    Jablonska K; Pula B; Zemla A; Owczarek T; Wojnar A; Rys J; Ambicka A; Podhorska-Okolow M; Ugorski M; Dziegiel P
    J Pineal Res; 2013 Apr; 54(3):334-45. PubMed ID: 23330677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-binding protein RBMS3 is expressed in activated hepatic stellate cells and liver fibrosis and increases expression of transcription factor Prx1.
    Fritz D; Stefanovic B
    J Mol Biol; 2007 Aug; 371(3):585-95. PubMed ID: 17586524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of RBMS3 Novel Potential Regulator of the EMT Phenomenon in Physiological and Pathological Processes.
    Górnicki T; Lambrinow J; Mrozowska M; Podhorska-Okołów M; Dzięgiel P; Grzegrzółka J
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer via Activation of miR-126-5p/β-catenin/CBP signaling.
    Wu G; Cao L; Zhu J; Tan Z; Tang M; Li Z; Hu Y; Yu R; Zhang S; Song L; Li J
    Clin Cancer Res; 2019 Feb; 25(3):1022-1035. PubMed ID: 30279231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma.
    Liang YN; Liu Y; Meng Q; Li X; Wang F; Yao G; Wang L; Fu S; Tong D
    Med Oncol; 2015 Feb; 32(2):459. PubMed ID: 25588924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
    Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
    Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA MEG3 regulates breast cancer proliferation and apoptosis through miR-141-3p/RBMS3 axis.
    Dong S; Ma M; Li M; Guo Y; Zuo X; Gu X; Zhang M; Shi Y
    Genomics; 2021 Jul; 113(4):1689-1704. PubMed ID: 33845141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.